Trials Impact Assessment Report

D6.3 Trials Impact Assessment Report [lead: EY; due: M36]: This report will summarize the approach and key evidences emerged along with the social, economic and organizational assessment performed under Task 6.6, including indications on the different perspectives of target stakeholders (e.g. patients, physicians, hospitals, public institutions, etc.).